Claforan Injection, Powder, For Solution
NDC Package 21586-031-02

11-digit billing NDC: 21586003102
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Claforan (cefotaxime) injection is cefotaxime is used to treat a wide variety of bacterial infections. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Sterimax Inc., this product is identified by NDC 21586-031 and is authorized under FDA application NDA050547.

Identification & Billing

NDC Package Code
21586-031-02
Package Description
10 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (21586-031-01)
Product Code
21586-031
11-Digit Billing Format
21586003102

Clinical Specifications

Proprietary Name
Claforan
Non-Proprietary Name
Cefotaxime
Substance Name
Cefotaxime Sodium
Dosage Form
Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
CEFOTAXIME SODIUM 1 g/1
Pharmacologic Class
Usage Information
Cefotaxime is used to treat a wide variety of bacterial infections. It may also be used to prevent infection from certain surgeries. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

Regulatory & Marketing

Labeler Name
Sterimax Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA050547
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-01-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 21586-031-02 identifies a specific commercial package of 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial (21586-031-01) of Claforan, a human prescription drug labeled by Sterimax Inc.. This injection, powder, for solution is formulated for intramuscular; intravenous use and contains cefotaxime sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sterimax Inc. on October 01, 2026. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Cefotaxime is used to treat a wide variety of bacterial infections. It may also be used to prevent infection from certain surgeries. This medication belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria.

How is this Sterimax Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 21586003102. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
21586-031-02
11-Digit CMS (5-4-2)
21586-0031-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.